- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Acceleron Pharma Inc.
Total 2360 results
-
UMN Pharma Inc.Completed
-
Astellas Pharma IncCompletedAtrial FibrillationGermany, Korea, Republic of, Australia, Poland, United Kingdom, Japan, South Africa, Russian Federation, Austria, Estonia, Thailand, Bulgaria, France, Spain, Ukraine, India, Israel, Hungary, Slovakia, Malaysia, Philippines, Czech... and more
-
Astellas Pharma IncCompletedVenous ThromboembolismJapan
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of AtorvastatinJapan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of EnalaprilJapan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM150Japan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Akela Pharma, Inc.Unknown
-
Quigley Pharma, Inc.CompletedDiabetic NeuropathyUnited States
-
Akros Pharma Inc.Completed
-
Akros Pharma Inc.CompletedType II HyperlipidemiaNetherlands
-
Akros Pharma Inc.Completed
-
Astellas Pharma IncCompletedLiver TransplantationUnited Kingdom, Germany, Spain, Belgium, Switzerland, Canada, Netherlands, Czech Republic, France, Hungary, Austria, Italy
-
Astellas Pharma IncCompletedKeratoconjunctivitis | ConjunctivitisJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma Global Development, Inc.Not yet recruitingClaudin 18.2 (CLDN18.2) Positive Metastatic Pancreatic Adenocarcinoma
-
Astellas Pharma Global Development, Inc.RecruitingNeurogenic Detrusor OveractivityPhilippines, Turkey, Belgium, Denmark
-
Astellas Pharma Global Development, Inc.RecruitingAcute Myeloid Leukemia (AML) | FLT3-mutated Acute Myeloid LeukemiaUnited States
-
Astellas Pharma Global Development, Inc.RecruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)United States, Canada, Germany, Italy, Spain, United Kingdom, France
-
Astellas Pharma Global Development, Inc.Active, not recruitingAdvanced Cancer | Advanced MalignanciesUnited States
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
-
Astellas Pharma Global Development, Inc.Active, not recruitingStargardt's Macular DystrophyItaly, United States, Israel, United Kingdom, Germany, Spain, Hungary, France
-
Astellas Pharma Global Development, Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States, Japan, Taiwan, Spain, Australia, Belgium, Canada, France, Germany, Italy, Korea, Republic of, Poland, United Kingdom
-
Astellas Pharma Global Development, Inc.Active, not recruitingAge-Related Macular Degeneration | Geographic AtrophyUnited States, Italy, Latvia, France, Israel, Germany, Spain, Hungary, Brazil, Canada, Argentina, Colombia, Croatia, Australia, Austria, Belgium, Czechia
-
Astellas Pharma Global Development, Inc.CompletedInvasive Aspergillosis | Invasive MucormycosisUnited States, Belgium, Spain
-
Astellas Pharma Global Development, Inc.TerminatedReduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen ExtractionUnited States
-
Astellas Pharma Global Development, Inc.CompletedMyelodysplastic Syndrome | Acute Myeloid Leukemia (AML)United States, Japan
-
Astellas Pharma Global Development, Inc.CompletedHot FlashesUnited States, Canada, Czechia, Hungary, Poland, Spain, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedRenal Impairment | Healthy VolunteersUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedHealthy SubjectsUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedTumors | Incurable Platinum Refractory Germ Cell TumorsUnited States
-
Astellas Pharma Global Development, Inc.TerminatedAcute Myeloid LeukemiaCanada, United States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
Astellas Pharma Global Development, Inc.CompletedHealthy | Hepatic ImpairmentUnited States
-
Astellas Pharma Global Development, Inc.CompletedInvasive Fungal InfectionUnited States
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder | Benign Prostatic HyperplasiaUnited States, Canada, Czechia, France, Germany, Italy, Poland, Spain, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedCLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction | CLDN18.2-positive Adenocarcinoma of Esophagus | CLDN18.2-positive Gastric AdenocarcinomaBulgaria, Czechia, Germany, Latvia, Russian Federation, Ukraine
-
Astellas Pharma Global Development, Inc.CompletedFibromyalgiaUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedArthritis, RheumatoidUnited States, Poland, Czechia, Bulgaria, Hungary, Mexico
-
Astellas Pharma Global Development, Inc.TerminatedNon-hematologic Malignancies | Pharmacokinetics of ASP9853United States